Sermorelin injections are a prescription peptide treatment that stimulates the pituitary gland to release growth hormone. Adult wellness use is not FDA-approved, and current adult products are compounded. Evidence for sleep, body composition, energy, and recovery is limited, so treatment should be clinician-guided with eligibility screening and monitoring.
Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.
See if you qualify →What are sermorelin injections?
Sermorelin injections contain sermorelin acetate, a lab-made version of part of growth hormone-releasing hormone, often called GHRH. GHRH is a brain signal that tells the pituitary gland to release growth hormone in pulses 1.
Sermorelin acetate, GHRH, growth hormone, and IGF-1 in plain English
Think of the growth-hormone axis as a message chain. The hypothalamus sends GHRH. The pituitary gland responds by releasing growth hormone. Growth hormone then signals the liver and other tissues to make insulin-like growth factor 1, or IGF-1, which clinicians may track as a downstream marker 2.
Sermorelin acetate is a GHRH analog and growth hormone secretagogue. “Secretagogue” means it asks the body to release a hormone it already makes. It is not human growth hormone, also called HGH 1.
How injections differ from taking human growth hormone directly
Human growth hormone injections bypass the pituitary gland. Sermorelin works upstream, at the pituitary gland, so normal feedback signals such as somatostatin still help shape growth hormone release 3.
That difference matters, but it does not make sermorelin risk-free. Any treatment that affects the growth-hormone axis can affect symptoms, IGF-1, fluid balance, and glucose handling, so monitoring is part of safe care 4.
What compounded sermorelin means today
Geref was the branded sermorelin product used for pediatric growth hormone deficiency. It is no longer marketed in the United States. Today, adult sermorelin treatment is generally discussed as compounded sermorelin injection via 503A pharmacy, compounded sermorelin nasal spray via 503A pharmacy, or compounded sermorelin tablets via 503A pharmacy.
At Chia, sermorelin is available as injection, nasal spray, and tablets when prescribed after a licensed-provider review. Plans currently start at $179/mo for sermorelin injection or nasal spray; see the product page for up-to-date pricing.
Quick facts about sermorelin injections
Sermorelin is prescription-only and works on the growth-hormone axis, not the GLP-1 pathway. The key safety point is not “online versus in-person”; it is whether a licensed clinician reviews your health history and whether a state-licensed 503A pharmacy dispenses the medication.
- Prescription-only peptide: sermorelin should be used only after clinical evaluation.
- Historical approved use: sermorelin was approved as Geref for pediatric growth hormone deficiency, then withdrawn from marketing; adult wellness use is not FDA-approved 1.
- Most studied route: injections have more direct clinical and pharmacology history than nasal spray or tablets.
- Not a GLP-1: sermorelin is not Ozempic, semaglutide, tirzepatide, or another GLP-1-based medication.
- Monitoring matters: clinicians may review symptoms, IGF-1, fasting glucose, thyroid function, and other metabolic markers depending on the patient.
What are sermorelin injections used for?
Sermorelin acetate was historically used for pediatric growth hormone deficiency, but adult wellness use is different. In adults, people often ask about sleep quality, exercise recovery, body composition, energy, and fatigue, but those goals are not established FDA-approved benefits.
Approved historical pediatric use versus current compounded adult use
The older Geref product was used in children with growth hormone deficiency. That history does not prove that compounded sermorelin improves adult wellness, extends lifespan, or changes body composition in healthy adults 1.
This is why we use careful language. Adult wellness goals are best described as off-label or investigational, depending on the context, and should be reviewed with a clinician.
Adult goals people ask about: sleep, recovery, body composition, energy
The interest comes from the role growth hormone plays in tissue repair, lean mass, fat metabolism, and sleep-linked hormone pulses. But a plausible mechanism is not the same as proven benefit. Broader growth-hormone and GHRH studies can guide questions, but they do not prove that compounded sermorelin produces predictable adult wellness results 3.
Side effects must be part of the same discussion. Injection-site reactions, headache, flushing, dizziness, and nausea have been reported with sermorelin or related use, and clinicians may watch glucose handling and IGF-1 depending on risk 1.
How do sermorelin injections work in the body?
Sermorelin injections bind to GHRH receptors on pituitary cells. That signal can trigger pulsatile growth hormone release, which may raise downstream IGF-1 in some people 2.
GHRH receptor signaling at the pituitary gland
The pituitary gland sits at the base of the brain. Sermorelin acts like a GHRH signal at this gland, encouraging it to release growth hormone into the bloodstream 1.
Pulsatile growth hormone release
Growth hormone normally rises and falls in pulses, with important pulses during sleep. Sermorelin works through the body’s own release system rather than replacing growth hormone directly, so feedback signals such as somatostatin remain part of the loop 3.
IGF-1 as a downstream marker providers may monitor
IGF-1 is not the same as growth hormone, but it reflects downstream growth-hormone activity. In endocrine practice, IGF-1 can help clinicians understand growth-hormone-axis activity and decide whether more evaluation is needed 4.
Why thyroid function and metabolic health can matter
Thyroid status, nutrition, sleep, insulin resistance, and other metabolic issues can affect fatigue and body composition. They can also change how a clinician interprets symptoms and labs. That is one reason we do not treat sermorelin as a stand-alone “anti-aging” shortcut.
What does the research actually show about sermorelin benefits?
Sermorelin-specific adult wellness research is limited. The honest answer is that there are mechanisms, older endocrine data, and indirect growth-hormone-axis research, but not large modern trials proving reliable improvements in sleep, recovery, body composition, energy, or human longevity.
Human evidence for sermorelin-specific adult wellness use
Sermorelin has a clinical history in growth hormone deficiency, and reviews describe its role as a GHRH analog that stimulates growth hormone release 1. But adult wellness claims are a different question. Large, sermorelin-specific randomized trials for longevity or general wellness are not established.
What broader GHRH and growth hormone studies can and cannot prove
Broader growth-hormone-axis studies help explain why people are interested in sermorelin. In adults with true growth hormone deficiency, diagnosis and treatment are handled through endocrine evaluation, and diagnostic testing may include agents such as macimorelin, which is FDA-approved for diagnosing adult growth hormone deficiency 5.
But adult growth hormone deficiency is a medical condition, not the same as normal aging or low energy. Evidence from diagnosed deficiency should not be stretched into a promise for healthy adults.
Why animal, cell, and biomarker findings are not human longevity claims
A biomarker change, animal result, or cell finding can be useful for research. It does not prove longer human life. For sermorelin, we do not present it as a treatment that reverses aging or extends lifespan.
Realistic expectations for sleep, recovery, body composition, and energy
If a clinician considers sermorelin, the goal is usually to track a person’s symptoms, labs, and tolerance over time. Individual results vary, and the most useful question is often whether objective markers and symptoms are moving in a safe, meaningful direction.
Possible upsides should be weighed with side effects and contraindications. A clinician may decide sermorelin is not appropriate if the health history raises concern, if labs do not support use, or if risks outweigh possible benefit.
3-min quiz
Considering sermorelin with clinician guidance?
Chia offers sermorelin as injection, nasal spray, and tablets after an online health questionnaire and licensed US provider review. If prescribed, medication is compounded by a state-licensed 503A pharmacy and shipped to your door. A prescription requires a medical evaluation and is not guaranteed. Compounded drugs are not FDA-approved.
What are the bad side effects of sermorelin?
Sermorelin side effects can include injection-site reactions, headache, flushing, dizziness, and nausea. Because sermorelin works on the growth-hormone axis, clinicians may also watch IGF-1 and metabolic markers such as fasting glucose 1.
Common side effects
- Injection-site redness, itching, swelling, or discomfort
- Headache
- Flushing or warmth
- Dizziness
- Nausea
Metabolic concerns providers may watch
Growth hormone can interact with glucose metabolism. In people with insulin resistance, diabetes risk, or changing weight, a clinician may review fasting glucose, A1C, medications, and symptoms before and during treatment 6.
When a clinician may decide sermorelin is not appropriate
A clinician may be cautious or decide against sermorelin in people with certain cancer histories, unexplained abnormal labs, pregnancy, breastfeeding, significant endocrine disease, or medication conflicts. The right decision depends on the full health history.
Why monitoring matters
Monitoring is not busywork. It helps separate “I feel different” from a safe, measurable response. It also helps catch side effects early, before a person self-adjusts in a risky way.
Is 3 months of sermorelin enough to know if it is working?
Three months may be enough to review tolerance, adherence, early symptoms, and some lab trends, but it is not a universal pass-fail point. Response timelines vary by age, sleep, nutrition, baseline hormone status, metabolic health, and the reason treatment was considered.
Early tracking may focus on side effects, sleep pattern, fatigue, and injection tolerance. Over several months, a clinician may decide whether IGF-1, glucose markers, body-composition measures, or symptoms support continuing, changing, or stopping treatment.
Do not self-adjust based on a calendar date. Sermorelin affects a hormone system, so changes should be reviewed with a clinician.
Is sermorelin the same as Ozempic?
Sermorelin is not Ozempic. Sermorelin acetate is a GHRH analog and growth hormone secretagogue. Ozempic is semaglutide, a GLP-1 receptor agonist FDA-approved for type 2 diabetes and certain cardiovascular and kidney-risk uses in specific patients 7.
Semaglutide is also the active ingredient in Wegovy, which is FDA-approved for chronic weight management in specific adults and adolescents 8. Compounded semaglutide via 503A pharmacy is different from the FDA-approved brand product and has no FDA-evaluated outcomes data.
| Question | Sermorelin | Semaglutide / Ozempic-type GLP-1 pathway | Tirzepatide pathway |
|---|---|---|---|
| Drug class | GHRH analog; growth hormone secretagogue | GLP-1 receptor agonist | GIP/GLP-1 receptor agonist |
| Main pathway | Pituitary gland → growth hormone → IGF-1 | Gut-brain metabolic signaling, appetite, glucose regulation | GIP and GLP-1 metabolic signaling |
| Primary weight-loss role | Not primarily a weight-loss medication | Semaglutide has FDA-approved weight-management use as Wegovy in eligible patients 8 | Tirzepatide has FDA-approved weight-management use as Zepbound in eligible patients 9 |
| Chia offering | Sermorelin: injection, nasal spray, tablets | Semaglutide: injection; microdosing plans available | Tirzepatide: tablets and injection; microdosing plans available |
How much weight can you lose with sermorelin injections?
Sermorelin injections should not be presented as a weight-loss drug. Some people ask about body composition because growth hormone is linked to lean tissue and fat metabolism, but scale-weight loss is not an established sermorelin outcome.
If your main goal is weight management, a GLP-1-based option may be more directly relevant for a clinician to discuss. Semaglutide and tirzepatide have been studied for weight management as active ingredients, with side effects that can include nausea, vomiting, diarrhea, constipation, gallbladder problems, pancreatitis risk, and contraindications such as certain thyroid cancer histories on their FDA labels 8, 9.
At Chia, we offer compounded semaglutide injection and compounded tirzepatide tablets or injection through licensed-provider evaluation. Compounded formulations are not FDA-approved, and results are not established for compounded formulations.
How do sermorelin injections compare with nasal spray and tablets?
Injection is the most studied route for sermorelin. Nasal spray and tablets may be easier for some people, but convenience should be balanced against evidence limits, handling, storage, and follow-up needs.
| Form | What to know | Evidence and practical trade-off | Offered at Chia? |
|---|---|---|---|
| Injection | Delivered under the skin with a small needle | Most studied route; requires injection comfort, storage awareness, and sharps handling | Yes — plans currently start at $179/mo |
| Nasal spray | Needle-free spray route | May be simpler day to day, but has less direct sermorelin evidence than injection | Yes — plans currently start at $179/mo |
| Tablets | Needle-free oral or tablet-based route as prescribed | Convenient, but peptide absorption and clinical evidence can be more limited than injection | Yes |
Good questions for a prescriber include: which route fits my goal, what monitoring is planned, how should the product be stored, what side effects should I report, and when should we reassess?
How can you access sermorelin injections through Chia?
Chia offers sermorelin as injection, nasal spray, and tablets. The process is fully online: you complete a short health questionnaire, then a licensed US provider reviews your history and prescribes only when clinically appropriate.
If prescribed, sermorelin is compounded in the US by a state-licensed 503A compounding pharmacy and shipped to your door. Dosing is provider-guided and adjusted over time. You can message your care team through the patient portal between visits.
Sermorelin may also appear in certain Chia protocols when clinically appropriate. Foundation Longevity includes Sermorelin Injection + NAD+ Injection + Glutathione Injection. Weight + Muscle includes Sermorelin Injection + choice of GLP-1.
| Chia option | What it includes | Current starting price |
|---|---|---|
| Sermorelin | Injection, nasal spray, or tablets | Injection and nasal spray plans currently start at $179/mo |
| Foundation Longevity | Sermorelin Injection + NAD+ Injection + Glutathione Injection | Plans currently start at $399/mo |
| Weight + Muscle | Sermorelin Injection + choice of GLP-1 | Plans currently start at $329/mo |
Who should talk with a clinician before considering sermorelin?
Anyone considering sermorelin should talk with a clinician first. This is especially important if you have fatigue, sleep problems, weight change, low exercise recovery, endocrine disease, diabetes risk, cancer history, pregnancy, breastfeeding, or complex medications.
A careful review may include symptoms, medication list, medical history, and pregnancy status. Depending on the person, possible baseline labs may include IGF-1, thyroid panel, fasting glucose, A1C, lipids, liver markers, kidney markers, or other metabolic tests.
The goal is not to “qualify” everyone. The goal is to decide whether the expected benefit, uncertainty, and safety profile make sense for one person.
What peptides stack well with sermorelin?
Sermorelin stacks are combinations that are commonly discussed in clinical or research practice, but combination-specific trials are limited. Stacks should not be treated as a do-it-yourself protocol.
Sermorelin with a GLP-1 for weight and muscle goals
A GLP-1-based treatment may target appetite and metabolic pathways, while sermorelin is aimed at the growth-hormone axis. Chia’s Weight + Muscle protocol combines Sermorelin Injection with a choice of GLP-1 when a licensed provider finds it appropriate.
The safety caveat is overlap in real life, not overlap in mechanism: nausea, nutrition changes, training load, glucose markers, and body-composition goals all need clinician oversight.
Sermorelin with NAD+
NAD+ is discussed for cellular energy pathways, while sermorelin works through pituitary growth-hormone signaling. Chia offers NAD+ separately and includes NAD+ Injection with Sermorelin Injection in Foundation Longevity.
The safety caveat is that more treatments mean more variables. Side effects, tolerability, medication handling, and goals should be reviewed together.
Sermorelin with glutathione
Glutathione is an antioxidant molecule, while sermorelin is a growth-hormone secretagogue. They are sometimes paired in longevity-style protocols, including Chia’s Foundation Longevity protocol, but that does not prove additive clinical outcomes.
The safety caveat is the same: combination-specific evidence is limited, and a clinician should decide whether each component is appropriate.
3-min quiz
Start with a licensed review
If sermorelin fits your goals, you can start with Chia’s online eligibility visit. Our providers review your health history and prescribe only where clinically appropriate. If prescribed, medication is compounded by a state-licensed 503A pharmacy and shipped to your door. A prescription is never guaranteed.
Most sermorelin injections use a small needle under the skin, so discomfort is usually brief. Some people can have redness, itching, swelling, or soreness at the injection site. A clinician can review technique and side effects.
Storage depends on the specific compounded product and pharmacy instructions. Follow the label and pharmacy guidance you receive, and ask your care team if the medication was left out or looks different.
Sermorelin can affect the growth-hormone axis, and IGF-1 is one marker clinicians may monitor. If IGF-1 rises more than expected or symptoms occur, your clinician may reassess whether treatment still makes sense.
Women can be evaluated for sermorelin, but it is not appropriate for everyone. Pregnancy status, breastfeeding, hormone history, metabolic health, cancer history, and medications should be reviewed by a clinician.
Sometimes a clinician may consider sermorelin with a GLP-1-based weight-management plan, but they are different treatments. Sermorelin is not a weight-loss drug. Compounded drugs are not FDA-approved, and a licensed provider should review risks, goals, and monitoring.
No. Current adult sermorelin products discussed here are compounded medications, and compounded drugs are not FDA-approved or reviewed by FDA for safety, effectiveness, or quality before dispensing.
Many growth-hormone secretagogues are restricted or banned by sports organizations. Athletes should check the rules for their sport and governing body before using any peptide or hormone-axis treatment.
References
- 1.Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999.
- 2.Merriam GR, Schwartz RS, Vitiello MV. Growth hormone-releasing hormone and growth hormone secretagogues in normal aging. Endocrine. 2003.
- 3.Muller EE, Locatelli V, Cocchi D. Neuroendocrine control of growth hormone secretion. Physiological Reviews. 1999.
- 4.Molitch ME, Clemmons DR, Malozowski S, Merriam GR, Vance ML; Endocrine Society. Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline. Journal of Clinical Endocrinology & Metabolism. 2011.
- 5.Garcia JM, Biller BMK, Korbonits M, et al. Macimorelin as a diagnostic test for adult growth hormone deficiency. Journal of Clinical Endocrinology & Metabolism. 2018.
- 6.Møller N, Jørgensen JOL. Effects of growth hormone on glucose, lipid, and protein metabolism in human subjects. Endocrine Reviews. 2009.
- 7.U.S. Food and Drug Administration. Ozempic (semaglutide) injection prescribing information. 2025.
- 8.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2025.
- 9.U.S. Food and Drug Administration. Zepbound (tirzepatide) injection prescribing information. 2025.
- 10.World Anti-Doping Agency. The 2026 Prohibited List: International Standard. 2026.
About this article
Chia Health Editorial Team — Evidence-reviewed health education
This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.
AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.
Get a personalized plan
See if GLP-1 is right for your body.
Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.
